Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 2
2011 1
2013 1
2014 3
2015 5
2016 4
2017 3
2018 2
2019 4
2020 3
2021 8
2022 9
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Jeon DS, Park CK, Kim SJ, Park CK, Chang YS, Jung CY, Lee SY, Lee SY, Ryu JS, Lee JE, Lee KY, Jang TW, Jang SH, Yoon SH, Lee SH, Choi CM, Kim HR, Kim YJ. Jeon DS, et al. Among authors: yoon sh. Thorac Cancer. 2024 Feb;15(6):448-457. doi: 10.1111/1759-7714.15213. Epub 2024 Jan 3. Thorac Cancer. 2024. PMID: 38171544 Free PMC article.
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data.
Choi J, Choi CM, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park JY, Kim YC, Oh IJ, Jung CY, Lee SH, Yoon SH, Lee SY, Jang TW. Choi J, et al. Among authors: yoon sh. Transl Lung Cancer Res. 2023 Nov 30;12(11):2275-2282. doi: 10.21037/tlcr-23-383. Epub 2023 Nov 28. Transl Lung Cancer Res. 2023. PMID: 38090523 Free PMC article.
Erratum: Correction of Affiliations in the Article "Validity of Outcome Prediction Scoring Systems in Korean Patients with Severe Adult Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation Therapy".
Lee S, Yeo HJ, Yoon SH, Lee SE, Cho WH, Jeon DS, Kim YS, Son BS, Kim DH. Lee S, et al. Among authors: yoon sh. J Korean Med Sci. 2023 Oct 30;38(42):e380. doi: 10.3346/jkms.2023.38.e380. J Korean Med Sci. 2023. PMID: 37904662 Free PMC article.
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Kim J, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim J, et al. Among authors: yoon sh. Transl Lung Cancer Res. 2023 Jun 30;12(6):1197-1209. doi: 10.21037/tlcr-22-832. Epub 2023 Jun 12. Transl Lung Cancer Res. 2023. PMID: 37425421 Free PMC article.
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study.
Kim T, Jang TW, Choi CM, Kim MH, Lee SY, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH, Oh HJ. Kim T, et al. Among authors: yoon sh. Cancer Res Treat. 2023 Oct;55(4):1152-1170. doi: 10.4143/crt.2023.493. Epub 2023 May 19. Cancer Res Treat. 2023. PMID: 37218139 Free PMC article.
58 results